Exosomes from Cancer Cells Could Predict Immunotherapy Responses
Immune-Evasion Mechanism May Help Explain the Differences in Responses to Immunotherapy
Commercializing Gene Therapies
Using High-Touch Services to Enhance Patient Outcomes
Literature Review: Cytometry with a View
Application of Imaging Flow Cytometry
On the Clock
Can Transcriptomics Help Find the Right Time to Administer Chemotherapy?
For full access to this article login to GEN Select now.
Overcoming Protein Production Hurdles
Increasing Capabilities Becomes Essential as the Biologics Market Grows Rapidly
- Recombinant antibodies have emerged as dominant players in the biopharma industry despite the copious quantities required for treatment. Although nonantibody biologics are typically produced at much smaller scale, are less complex, and have limited secondary modifications, their production is also fraught with challenges. Not surprisingly overcoming protein-production hurdles was ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.